Pittenger & Anderson Inc. Sells 373 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Pittenger & Anderson Inc. trimmed its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 17.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,805 shares of the biotechnology company’s stock after selling 373 shares during the quarter. Pittenger & Anderson Inc.’s holdings in Axon Enterprise were worth $1,073,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. Groupama Asset Managment purchased a new position in Axon Enterprise during the third quarter valued at $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise during the third quarter valued at $120,553,000. International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter worth about $871,860,000. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

NASDAQ AXON opened at $683.41 on Tuesday. The company has a 50-day moving average price of $624.03 and a 200-day moving average price of $511.87. Axon Enterprise, Inc. has a 52 week low of $260.27 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $52.11 billion, a P/E ratio of 176.59, a PEG ratio of 6.79 and a beta of 1.05.

Insider Activity at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on AXON. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Finally, JMP Securities increased their price objective on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.